Related Topics News -

     
 Detail   |   Print    Next page > 
     
軒竹生物安奈拉唑鈉腸溶片獲國家藥監局受理RE新適應症申請
2026-06-30T  
四環醫藥 旗下安久衛根除幽門螺桿菌III期臨床完成首例患者入組
2026-06-22T  
軒竹生物安奈拉唑鈉根除幽門螺桿菌之III期臨床試驗完成首例患者入組
2026-06-22T  
軒竹生物完成H股全流通
2026-05-12T  
軒竹生物NG-350A臨床相關數據於AACR發佈
2026-04-20T  
軒竹生物地羅阿克III期臨床研究數據於AACR展示
2026-04-19T  
四環醫藥安奈拉唑鈉腸溶片獲批開展III期臨床試驗
2026-04-15T  
軒竹生物:安奈拉唑鈉新適應症獲批開展III期臨床試驗
2026-04-15T  
軒竹生物擬實施H股全流通獲中證監備案
2026-04-13T  
軒竹生物授出兩款藥品商業化許可 料獲首付款及後續可能付款逾1億美元
2026-04-09T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.